China Pharmaceutical International Exchange Center under the SFDA, Beijing Intellectual Property Right Exchange and Capital Science and Technology Group recently signed an agreement to jointly establish Beijing International Pharmaceutical Technology Transfer Platform, a service agency which aims to provide relevant integrated services, such as consulting, IP evaluation, fund raising and M&A planning, to international and local pharmaceutical companies, CROs and investment firms.